These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21131780)

  • 101. Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer.
    Liu Y; Marks K; Cowley GS; Carretero J; Liu Q; Nieland TJ; Xu C; Cohoon TJ; Gao P; Zhang Y; Chen Z; Altabef AB; Tchaicha JH; Wang X; Choe S; Driggers EM; Zhang J; Bailey ST; Sharpless NE; Hayes DN; Patel NM; Janne PA; Bardeesy N; Engelman JA; Manning BD; Shaw RJ; Asara JM; Scully R; Kimmelman A; Byers LA; Gibbons DL; Wistuba II; Heymach JV; Kwiatkowski DJ; Kim WY; Kung AL; Gray NS; Root DE; Cantley LC; Wong KK
    Cancer Discov; 2013 Aug; 3(8):870-9. PubMed ID: 23715154
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response.
    McCubrey JA; Steelman LS; Chappell WH; Abrams SL; Montalto G; Cervello M; Nicoletti F; Fagone P; Malaponte G; Mazzarino MC; Candido S; Libra M; Bäsecke J; Mijatovic S; Maksimovic-Ivanic D; Milella M; Tafuri A; Cocco L; Evangelisti C; Chiarini F; Martelli AM
    Oncotarget; 2012 Sep; 3(9):954-87. PubMed ID: 23006971
    [TBL] [Abstract][Full Text] [Related]  

  • 103. A thymidylate synthase ternary complex-specific antibody, FTS, permits functional monitoring of fluoropyrimidines dosing.
    Patel K; Yerram SR; Azad NA; Kern SE
    Oncotarget; 2012 Jul; 3(7):678-85. PubMed ID: 22824673
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Expression of uracil DNA glycosylase (UDG) does not affect cellular sensitivity to thymidylate synthase (TS) inhibition.
    Welsh SJ; Hobbs S; Aherne GW
    Eur J Cancer; 2003 Feb; 39(3):378-87. PubMed ID: 12565992
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Regulation of NEIL1 protein abundance by RAD9 is important for efficient base excision repair.
    Panigrahi SK; Hopkins KM; Lieberman HB
    Nucleic Acids Res; 2015 May; 43(9):4531-46. PubMed ID: 25873625
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Effect of the thymidylate synthase inhibitors on dUTP and TTP pool levels and the activities of DNA repair glycosylases on uracil and 5-fluorouracil in DNA.
    Grogan BC; Parker JB; Guminski AF; Stivers JT
    Biochemistry; 2011 Feb; 50(5):618-27. PubMed ID: 21222484
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines.
    Barnes MJ; Estlin EJ; Taylor GA; Aherne GW; Hardcastle A; McGuire JJ; Calvete JA; Lunec J; Pearson AD; Newell DR
    Clin Cancer Res; 1999 Sep; 5(9):2548-58. PubMed ID: 10499632
    [TBL] [Abstract][Full Text] [Related]  

  • 108. The C-terminal Domain (CTD) of Human DNA Glycosylase NEIL1 Is Required for Forming BERosome Repair Complex with DNA Replication Proteins at the Replicating Genome: DOMINANT NEGATIVE FUNCTION OF THE CTD.
    Hegde PM; Dutta A; Sengupta S; Mitra J; Adhikari S; Tomkinson AE; Li GM; Boldogh I; Hazra TK; Mitra S; Hegde ML
    J Biol Chem; 2015 Aug; 290(34):20919-20933. PubMed ID: 26134572
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Phenotypic enhancement of thymidylate synthetase pathway inhibitors following ablation of Neil1 DNA glycosylase/lyase.
    Taricani L; Shanahan F; Pierce RH; Guzi TJ; Parry D
    Cell Cycle; 2010 Dec; 9(24):4876-83. PubMed ID: 21131780
    [TBL] [Abstract][Full Text] [Related]  

  • 110. The role of dUTPase and uracil-DNA repair in cancer chemotherapy.
    Ladner RD
    Curr Protein Pept Sci; 2001 Dec; 2(4):361-70. PubMed ID: 12374095
    [TBL] [Abstract][Full Text] [Related]  

  • 111. The Fanconi anemia pathway promotes DNA glycosylase-dependent excision of interstrand DNA crosslinks.
    Macé-Aimé G; Couvé S; Khassenov B; Rosselli F; Saparbaev MK
    Environ Mol Mutagen; 2010 Jul; 51(6):508-19. PubMed ID: 20120016
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Downstream molecular determinants of response to 5-fluorouracil and antifolate thymidylate synthase inhibitors.
    Van Triest B; Pinedo HM; Giaccone G; Peters GJ
    Ann Oncol; 2000 Apr; 11(4):385-91. PubMed ID: 10847455
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Folate-based thymidylate synthase inhibitors as anticancer drugs.
    Jackman AL; Calvert AH
    Ann Oncol; 1995 Nov; 6(9):871-81. PubMed ID: 8624289
    [TBL] [Abstract][Full Text] [Related]  

  • 114.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 115.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 116.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.